66658-112 : Kepivance 6.25 mg/1.2ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 66658-112
Labeler: Swedish Orphan Biovitrum Ab (Publ)
Product Type: Human Prescription Drug
Drug Name:  Kepivance
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: BLA125103
Rev. Date: 


NDC Package Codes:

  • 66658-112-03: 3 VIAL, SINGLE‑USE IN 1 CARTON (66658‑112‑03) > 1.2 ML IN 1 VIAL, SINGLE‑USE (66658‑112‑01)
  • 66658-112-06: 6 VIAL, SINGLE‑USE IN 1 CARTON (66658‑112‑06) > 1.2 ML IN 1 VIAL, SINGLE‑USE (66658‑112‑01)
  • 66658-112-24: 4 CARTON IN 1 BOX (66658‑112‑24) > 6 VIAL, SINGLE‑USE IN 1 CARTON (66658‑112‑06) > 1.2 ML IN 1 VIAL, SINGLE‑USE (66658‑112‑01)

Active Ingredients:

  • Palifermin

Dosage Strength:

  • 6.25 mg/1.2mL

Pharmaceutical Classes:

  • Fibroblast Growth Factor 7 [Chemical/Ingredient]
  • Increased Epithelial Proliferation [PE]
  • Mucocutaneous Epithelial Cell Growth Factor [EPC]

Related Products:

Based on records with the same trade name.
  • 66658-113 Kepivance 5.16 mg/1.2ml Intravenous Injection, Powder, Lyophilized, for Solution by Swedish Orphan Biovitrum Ab (Publ)

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 66658-112 QR Code

< Prev: 66658-110Next: 66658-113 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.